Logo image of VSEE

VSEE HEALTH INC (VSEE) Stock Fundamental Analysis

USA - NASDAQ:VSEE - US92919Y1029 - Common Stock

1.02 USD
+0.03 (+3.03%)
Last: 11/4/2025, 8:00:02 PM
1.03 USD
+0.01 (+0.98%)
Pre-Market: 11/5/2025, 8:42:11 AM
Fundamental Rating

1

VSEE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of VSEE have multiple concerns. VSEE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VSEE had negative earnings in the past year.
VSEE had a negative operating cash flow in the past year.
VSEE had negative earnings in each of the past 5 years.
VSEE had a negative operating cash flow in each of the past 5 years.
VSEE Yearly Net Income VS EBIT VS OCF VS FCFVSEE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

VSEE has a worse Return On Assets (-288.62%) than 97.14% of its industry peers.
Industry RankSector Rank
ROA -288.62%
ROE N/A
ROIC N/A
ROA(3y)-266.08%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSEE Yearly ROA, ROE, ROICVSEE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100K 200K 300K

1.3 Margins

Looking at the Gross Margin, with a value of 68.87%, VSEE is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
VSEE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSEE Yearly Profit, Operating, Gross MarginsVSEE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

VSEE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VSEE has been increased compared to 1 year ago.
VSEE has a better debt/assets ratio than last year.
VSEE Yearly Shares OutstandingVSEE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
VSEE Yearly Total Debt VS Total AssetsVSEE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -5.43, we must say that VSEE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VSEE (-5.43) is worse than 74.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.43
ROIC/WACCN/A
WACC9.15%
VSEE Yearly LT Debt VS Equity VS FCFVSEE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

VSEE has a Current Ratio of 0.16. This is a bad value and indicates that VSEE is not financially healthy enough and could expect problems in meeting its short term obligations.
VSEE has a worse Current ratio (0.16) than 94.29% of its industry peers.
VSEE has a Quick Ratio of 0.16. This is a bad value and indicates that VSEE is not financially healthy enough and could expect problems in meeting its short term obligations.
VSEE has a worse Quick ratio (0.16) than 94.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
VSEE Yearly Current Assets VS Current LiabilitesVSEE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for VSEE have decreased strongly by -253.79% in the last year.
Looking at the last year, VSEE shows a very strong growth in Revenue. The Revenue has grown by 80.74%.
EPS 1Y (TTM)-253.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.91%
Revenue 1Y (TTM)80.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -182.84% on average over the next years. This is quite bad
The Revenue is expected to grow by 46.40% on average over the next years. This is a very strong growth
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

VSEE Yearly Revenue VS EstimatesVSEE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M 20M
VSEE Yearly EPS VS EstimatesVSEE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VSEE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VSEE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSEE Price Earnings VS Forward Price EarningsVSEE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSEE Per share dataVSEE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

VSEE's earnings are expected to decrease with -182.84% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-182.84%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VSEE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VSEE HEALTH INC

NASDAQ:VSEE (11/4/2025, 8:00:02 PM)

Premarket: 1.03 +0.01 (+0.98%)

1.02

+0.03 (+3.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-15 2025-10-15
Earnings (Next)11-13 2025-11-13
Inst Owners4.5%
Inst Owner Change262.01%
Ins Owners38.49%
Ins Owner Change0%
Market Cap17.36M
Revenue(TTM)10.42M
Net Income(TTM)-57702000
Analysts82.86
Price Target5.1 (400%)
Short Float %0.12%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.67
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.94
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.61
BVpS0
TBVpS-0.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -288.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.87%
FCFM N/A
ROA(3y)-266.08%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.01%
Cap/Sales 0.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z -5.43
F-Score4
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-253.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.91%
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)80.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-80.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-817.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-815.19%
OCF growth 3YN/A
OCF growth 5YN/A

VSEE HEALTH INC / VSEE FAQ

What is the ChartMill fundamental rating of VSEE HEALTH INC (VSEE) stock?

ChartMill assigns a fundamental rating of 1 / 10 to VSEE.


What is the valuation status for VSEE stock?

ChartMill assigns a valuation rating of 0 / 10 to VSEE HEALTH INC (VSEE). This can be considered as Overvalued.


How profitable is VSEE HEALTH INC (VSEE) stock?

VSEE HEALTH INC (VSEE) has a profitability rating of 1 / 10.


What is the financial health of VSEE HEALTH INC (VSEE) stock?

The financial health rating of VSEE HEALTH INC (VSEE) is 0 / 10.